Rekombinanter TNFSF4 (Oxelumab Biosimilar) Antikörper

Produktnummer ABIN5564244

Der Human Monoklonal anti-TNFSF4 (Oxelumab Biosimilar) Antikörper wird verwendet zum Nachweis von TNFSF4 (Oxelumab Biosimilar) in Proben von Human. Er wurde validiert für FACS und Func.

Kurzübersicht für Rekombinanter TNFSF4 (Oxelumab Biosimilar) Antikörper (ABIN5564244)

Target: TNFSF4 (Oxelumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Reaktivität: Human

Wirt: Human

Klonalität: Monoklonal

Konjugat: Dieser TNFSF4 (Oxelumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), Functional Studies (Func)

Klon: R4930

Produktdetails anti-TNFSF4 (Oxelumab Biosimilar) Antikörper

Verwendungszweck: anti-OX40L (human), mAb (rec.) (blocking) (R4930) (preservative free)

Spezifität: Recognizes human OX40L.

Produktmerkmale: Recombinant Antibody. Recognizes human OX40L. Species cross-reactivity: Human. Clone: R4930. Isotype: Human IgG1kappa. Applications: FACS, FUNC, FUNC (Blocking). Host: CHO cells. Liquid. In PBS. OX40L is a membrane-expressed cytokine that belongs to the TNF ligand family. It acts as costimulator through interaction with its ligand OX40 on T cells, stimulating T cell activation, proliferation and cytokine production. OX40L is expressed on antigen presenting cells including B cells, dendritic cells, mast cells and endothelium.

Reinheit: >95 % (SDS-PAGE)

Endotoxin-Niveau: <0.001EU/μg

Immunogen: Recombinant human OX40L.

Isotyp: IgG1 kappa

Anwendungsinformationen

Kommentare:

This antibody is a biosimilar generically called Oxelumab (CAS 1186098-83-8) and originally developed by Genentech. Oxelumab is a OX40 ligand blocker designed for the prevention of allergen-induced airway inflammation in adults with mild asthma. Potentially other application areas are transplantation and autoimmunity research or protection against inflammation-driven fibrosis.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: In PBS.

Konservierungsmittel: Without preservative

Handhabung: Avoid freeze/thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung:

+4°C

-20°C

Stable for at least 1 year after receipt when stored at -20°C. Stable for at least 3 months after receipt when stored at +4°C.

Haltbarkeit: 12 months

Details zu TNFSF4 (Oxelumab Biosimilar)

Target: TNFSF4 (Oxelumab Biosimilar)

Substanzklasse: Biosimilar

Hintergrund:

Alternate Names/Synonyms: CD252, CD134L, OX40 Ligand, TNFSF4, Tumor Necrosis Factor Superfamily Member 4, TAX Transcriptionally-activated Glycoprotein 1, TXGP1, gp34

Product Description: OX40L [CD252, CD134L] is a membrane-expressed cytokine that belongs to the TNF ligand family. It acts as costimulator through interaction with its ligand OX40 on T cells, stimulating T cell activation, proliferation and cytokine production. OX40L is expressed on antigen presenting cells including B cells, dendritic cells, mast cells and endothelium.

UniProt: P23510